Sunscreen Data Guidance Risk/Benefit Balance Uneven – Comments

FDA's suggestion of maximal use trials to assess the systemic absorption potential for proposed sunscreen ingredients will delay consumer access to new broad-spectrum sunscreens without a sound scientific basis, say PASS, the American Cancer Society and American Academy of Dermatology Association.